Casdin Capital’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46M | Buy |
|
|||||
|
2025
Q1 | $18.3M | Hold |
|
|||||
|
2024
Q4 | $22.5M | Hold |
|
|||||
|
2024
Q3 | $19.3M | Buy |
|
|||||
|
2024
Q2 | $14.9M | Hold |
|
|||||
|
2024
Q1 | $40.6M | Buy |
|
|||||
|
2023
Q4 | $41.9M | Buy |
|
|||||
|
2023
Q3 | $39.2M | Buy |
|
|||||
|
2023
Q2 | $44.3M | Buy |
|
|||||
|
2023
Q1 | $30.6M | Sell |
|
|||||
|
2022
Q4 | $44.3M | Sell |
|
|||||
|
2022
Q3 | $109M | Buy |
|
|||||
|
2022
Q2 | $48M | Hold |
|
|||||
|
2022
Q1 | $71.6M | Hold |
|
|||||
|
2021
Q4 | $116M | Buy |
|
|||||
|
2021
Q3 | $143M | Hold |
|
|||||
|
2021
Q2 | $183M | Buy |
|